Literature DB >> 21289128

Vif substitution enables persistent infection of pig-tailed macaques by human immunodeficiency virus type 1.

Rajesh Thippeshappa1, Patricia Polacino, Monica T Yu Kimata, Edward B Siwak, David Anderson, Weiming Wang, Laura Sherwood, Reetakshi Arora, Michael Wen, Paul Zhou, Shiu-Lok Hu, Jason T Kimata.   

Abstract

Among Old World monkeys, pig-tailed macaques (Pt) are uniquely susceptible to human immunodeficiency virus type 1 (HIV-1), although the infection does not persist. We demonstrate that the susceptibility of Pt T cells to HIV-1 infection is due to the absence of postentry inhibition by a TRIM5 isoform. Notably, substitution of the viral infectivity factor protein, Vif, with that from pathogenic SIVmne enabled replication of HIV-1 in Pt T cells in vitro. When inoculated into juvenile pig-tailed macaques, the Pt-tropic HIV-1 persistently replicated for more than 1.5 to 2 years, producing low but measurable plasma viral loads and persistent proviral DNA in peripheral blood mononuclear cells. It also elicited strong antibody responses. However, there was no decline in CD4(+) T cells or evidence of disease. Surprisingly, the Pt-tropic HIV-1 was rapidly controlled when inoculated into newborn Pt macaques, although it transiently rebounded after 6 months. We identified two notable differences between the Pt-tropic HIV-1 and SIVmne. First, SIV Vif does not associate with Pt-tropic HIV-1 viral particles. Second, while Pt-tropic HIV-1 degrades both Pt APOBEC3G and APOBEC3F, it prevents their inclusion in virions to a lesser extent than pathogenic SIVmne. Thus, while SIV Vif is necessary for persistent infection by Pt-tropic HIV-1, improved expression and inhibition of APOBEC3 proteins may be required for robust viral replication in vivo. Additional adaptation of the virus may also be necessary to enhance viral replication. Nevertheless, our data suggest the potential for the pig-tailed macaque to be developed as an animal model of HIV-1 infection and disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21289128      PMCID: PMC3126129          DOI: 10.1128/JVI.02438-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  95 in total

1.  Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression.

Authors:  J T Kimata; L Kuller; D B Anderson; P Dailey; J Overbaugh
Journal:  Nat Med       Date:  1999-05       Impact factor: 53.440

2.  Generation of simian-tropic HIV-1 by restriction factor evasion.

Authors:  Theodora Hatziioannou; Michael Princiotta; Michael Piatak; Fang Yuan; Fengwen Zhang; Jeffrey D Lifson; Paul D Bieniasz
Journal:  Science       Date:  2006-10-06       Impact factor: 47.728

3.  Induction of AIDS in rhesus monkeys by a recombinant simian immunodeficiency virus expressing nef of human immunodeficiency virus type 1.

Authors:  L Alexander; Z Du; A Y Howe; S Czajak; R C Desrosiers
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

4.  STAT1-independent cell type-specific regulation of antiviral APOBEC3G by IFN-alpha.

Authors:  Phuong Thi Nguyen Sarkis; Songcheng Ying; Rongzhen Xu; Xiao-Fang Yu
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

5.  The human immunodeficiency virus type 1 nef gene can to a large extent replace simian immunodeficiency virus nef in vivo.

Authors:  F Kirchhoff; J Münch; S Carl; N Stolte; K Mätz-Rensing; D Fuchs; P T Haaft; J L Heeney; T Swigut; J Skowronski; C Stahl-Hennig
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

6.  Alpha interferon potently enhances the anti-human immunodeficiency virus type 1 activity of APOBEC3G in resting primary CD4 T cells.

Authors:  Keyang Chen; Jialing Huang; Chune Zhang; Sophia Huang; Giuseppe Nunnari; Feng-xiang Wang; Xiangrong Tong; Ling Gao; Kristi Nikisher; Hui Zhang
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

7.  Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions.

Authors:  M Dettenhofer; X F Yu
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

8.  In vitro HIV-1 infection in Macaca nemestrina PBMCs is blocked at a step beyond reverse transcription.

Authors:  L E Kimball; M L Bosch
Journal:  J Med Primatol       Date:  1998 Apr-Jun       Impact factor: 0.667

9.  Antiviral potency of APOBEC proteins does not correlate with cytidine deamination.

Authors:  Kate N Bishop; Rebecca K Holmes; Michael H Malim
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

Review 10.  Origins of HIV and the evolution of resistance to AIDS.

Authors:  Jonathan L Heeney; Angus G Dalgleish; Robin A Weiss
Journal:  Science       Date:  2006-07-28       Impact factor: 47.728

View more
  26 in total

1.  Efficient Transduction of Human and Rhesus Macaque Primary T Cells by a Modified Human Immunodeficiency Virus Type 1-Based Lentiviral Vector.

Authors:  Huan He; Jing Xue; Weiming Wang; Lihong Liu; Chaobaihui Ye; Zhe Cong; Jason T Kimata; Chuan Qin; Paul Zhou
Journal:  Hum Gene Ther       Date:  2016-12-29       Impact factor: 5.695

2.  Replication potentials of HIV-1/HSIV in PBMCs from northern pig-tailed macaque (Macaca leonina).

Authors:  Ai-Hua Lei; Gao-Hong Zhang; Ren-Rong Tian; Jia-Wu Zhu; Hong-Yi Zheng; Wei Pang; Yong-Tang Zheng
Journal:  Dongwuxue Yanjiu       Date:  2014-05

3.  The TRIMCyp genotype in four species of macaques in China.

Authors:  Chang-Qing Yu; Lei Na; Xiao-Ling Lv; Jian-Dong Liu; Xiao-Ming Liu; Fang Ji; Yong-Hui Zheng; Hong-Li Du; Xian-Gang Kong; Jian-Hua Zhou
Journal:  Immunogenetics       Date:  2012-12-12       Impact factor: 2.846

4.  A species-specific amino acid difference in the macaque CD4 receptor restricts replication by global circulating HIV-1 variants representing viruses from recent infection.

Authors:  Daryl Humes; Sandra Emery; Elizabeth Laws; Julie Overbaugh
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

5.  Flow cytometric characterizations of leukocyte subpopulations in the peripheral blood of northern pig-tailed macaques (Macaca leonina).

Authors:  Hong-Yi Zheng; Ming-Xu Zhang; Lin-Tao Zhang; Xiao-Liang Zhang; Wei Pang; Long-Bao Lyu; Yong-Tang Zheng
Journal:  Dongwuxue Yanjiu       Date:  2014-11-18

Review 6.  Animal models for HIV/AIDS research.

Authors:  Theodora Hatziioannou; David T Evans
Journal:  Nat Rev Microbiol       Date:  2012-12       Impact factor: 60.633

7.  The Glycosylphosphatidylinositol-Anchored Variable Region of Llama Heavy Chain-Only Antibody JM4 Efficiently Blocks both Cell-Free and T Cell-T Cell Transmission of Human Immunodeficiency Virus Type 1.

Authors:  Lihong Liu; Weiming Wang; Julie Matz; Chaobaihui Ye; Lucie Bracq; Jerome Delon; Jason T Kimata; Zhiwei Chen; Serge Benichou; Paul Zhou
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

8.  Generation of rhesus macaque-tropic HIV-1 clones that are resistant to major anti-HIV-1 restriction factors.

Authors:  Masako Nomaguchi; Masaru Yokoyama; Ken Kono; Emi E Nakayama; Tatsuo Shioda; Naoya Doi; Sachi Fujiwara; Akatsuki Saito; Hirofumi Akari; Kei Miyakawa; Akihide Ryo; Hirotaka Ode; Yasumasa Iwatani; Tomoyuki Miura; Tatsuhiko Igarashi; Hironori Sato; Akio Adachi
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

9.  A variant macaque-tropic human immunodeficiency virus type 1 is resistant to alpha interferon-induced restriction in pig-tailed macaque CD4+ T cells.

Authors:  Rajesh Thippeshappa; Hongmei Ruan; Weiming Wang; Paul Zhou; Jason T Kimata
Journal:  J Virol       Date:  2013-04-03       Impact factor: 5.103

Review 10.  Considerations in the development of nonhuman primate models of combination antiretroviral therapy for studies of AIDS virus suppression, residual virus, and curative strategies.

Authors:  Gregory Q Del Prete; Jeffrey D Lifson
Journal:  Curr Opin HIV AIDS       Date:  2013-07       Impact factor: 4.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.